Key result
Adding phenylephrine to high-dose insulin fails to improve survival or hemodynamics in porcine nifedipine-induced shock.
Why the study?
Does the addition of phenylephrine to high-dose insulin improve survival or hemodynamics in a porcine model of dihydropyridine-induced cardiogenic shock?
Does the addition of phenylephrine to high-dose insulin improve survival or hemodynamics in a porcine model of dihydropyridine-induced cardiogenic shock?
In a porcine model of nifedipine-induced cardiogenic shock, the addition of phenylephrine to high-dose insulin therapy did not improve mortality or hemodynamics compared to high-dose insulin alone.
Answers are grounded in this paper and cite their sources.
Adding phenylephrine to HDI yields no hemodynamic or survival benefit in this porcine model; leaves open vasopressor utility in human dihydropyridine toxicity.
INTRODUCTION: Vasopressors are commonly used for calcium channel blocker (CCB)-induced cardiogenic shock after calcium and high-dose insulin (HDI). Vasopressor therapy is frequently used in combination with HDI to increase blood pressure and improve outcome. However, no studies have compared the efficacy of HDI to the combination of a vasopressor and HDI in dihydropyridine overdose. We conducted a study to compare the efficacy of HDI to phenylephrine (PE) plus HDI in a porcine model of dihydropyridine toxicity. METHODS: Cardiogenic shock was induced by administering a nifedipine (NP) infusion of 0.0125 mcg/kg/min until a point of toxicity, defined as a 25% decrease in the baseline product of mean arterial pressure (MAP) × cardiac output (CO). Each arm was resuscitated with 20 mL/kg of saline (NS). The nifedipine infusion continued throughout a 4-h resuscitation protocol. The HDI group was titrated up to 10 units/kg/h of insulin and the HDI/PE group was titrated up to a dose of HDI 10 units/kg/h plus PE 3.6 mcg/kg/min. RESULTS: No baseline differences were found among groups including time to toxicity. Survival was not different between the HDI and HDI/PE arms. When comparing the HDI to the HDI/PE arm no differences were found for cardiac index (CI) (p = 0.06), systemic vascular resistance (p = 0.34), heart rate (HR) (p = 0.95), mean arterial pressure (p = 0.99), pulmonary vascular resistance (PVR) (p = 0.07), or base excess (p = 0.36). CONCLUSION: In this model of nifedipine-induced cardiogenic shock, the addition of PE to HDI therapy did not improve mortality, cardiac output, blood pressure, systemic vascular resistance (SVR), or base excess.
No takes yet. Share an insight, caveat, or question.
Engebretsen et al. (2010) studied Dihydropyridine toxicity / nifedipine-induced cardiogenic shock. Phenylephrine (PE) plus high-dose insulin (HDI) vs. HDI alone (up to 10 units/kg/h) was evaluated on Survival and hemodynamics (cardiac index, systemic vascular resistance, heart rate, mean arterial pressure, pulmonary vascular resistance, base excess). In a porcine model of nifedipine-induced cardiogenic shock, adding phenylephrine to high-dose insulin did not improve survival, cardiac index, or mean arterial pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: